Lignocaine is one of 88 small molecule programs targeting Hemorrhoid. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
61 competitors in Cataract
Avelox
Eylea
Decadron
Bromday
Toradol
Precedex
Lovenox
Cipro
Voltaren
Levaquin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details